Literature DB >> 20801723

Vascular endothelial growth factor attenuates status epilepticus-induced behavioral impairments in rats.

Jamee N Nicoletti1, Janice Lenzer, Elisa A Salerni, Sachin K Shah, Ahmed Elkady, Sidra Khalid, Dean Quinteros, Francis Rotella, David Betancourth, Susan D Croll.   

Abstract

Vascular endothelial growth factor (VEGF) is a vascular growth factor more recently recognized as a neurotrophic factor (for review, see Storkebaum E, Lambrechts D, Carmeliet P. BioEssays 2004;26:943-54). We previously reported that endogenous VEGF protein is dramatically upregulated after pilocarpine-induced status epilepticus in the rat, and that intra-hippocampal infusions of recombinant human VEGF significantly protected against the loss of hippocampal CA1 neurons in this model (Nicoletti JN, Shah SK, McCloskey DP, et al. Neuroscience 2008;151:232-41). We hypothesized that we would see a preservation of cognitive and emotional functioning with VEGF treatment accompanying the neuroprotection previously observed in this paradigm. Using the Morris water maze to evaluate learning and memory, and the light-dark task to assess anxiety, we found a selective profile of preservation. Specifically, VEGF completely preserved normal anxiety functioning and partially but significantly protected learning and memory after status epilepticus. To determine whether the ability of VEGF to attenuate behavioral deficits was accompanied by sustained preservation of hippocampal neurons, we stereologically estimated CA1 pyramidal neuron densities 4 weeks after status epilepticus. At this time point, we found no significant difference in neuronal densities between VEGF- and control-treated status epilepticus animals, suggesting that VEGF could have protected hippocampal functioning independent of its neuroprotective effect.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801723      PMCID: PMC2996482          DOI: 10.1016/j.yebeh.2010.07.011

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  32 in total

Review 1.  VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection.

Authors:  Erik Storkebaum; Diether Lambrechts; Peter Carmeliet
Journal:  Bioessays       Date:  2004-09       Impact factor: 4.345

2.  Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator.

Authors:  M J West; L Slomianka; H J Gundersen
Journal:  Anat Rec       Date:  1991-12

3.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

4.  Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology.

Authors:  R E Watson; S J Wiegand; R W Clough; G E Hoffman
Journal:  Peptides       Date:  1986 Jan-Feb       Impact factor: 3.750

5.  The neuropsychological and emotional consequences of living with intractable temporal lobe epilepsy: implications for clinical management.

Authors:  Pascale M Moore; Gus A Baker
Journal:  Seizure       Date:  2002-06       Impact factor: 3.184

6.  Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study.

Authors:  Darren Fuerst; Jagdish Shah; Aashit Shah; Craig Watson
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

7.  Seizure-induced changes in place cell physiology: relationship to spatial memory.

Authors:  Xianzeng Liu; Robert U Muller; Li-Tung Huang; John L Kubie; Alexander Rotenberg; Bruno Rivard; Maria Roberta Cilio; Gregory L Holmes
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

8.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5.

Authors:  R G Morris; E Anderson; G S Lynch; M Baudry
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

9.  Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy.

Authors:  Regula S Briellmann; Samuel F Berkovic; Ari Syngeniotis; Mark A King; Graeme D Jackson
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

Review 10.  Neuropsychological investigation of temporal lobe epilepsy.

Authors:  L H Goldstein
Journal:  J R Soc Med       Date:  1991-08       Impact factor: 18.000

View more
  12 in total

1.  Increased placental growth factor in cerebrospinal fluid of patients with epilepsy.

Authors:  Yali Xu; Ying Zhang; Zhenli Guo; Hongxiang Yin; Kebin Zeng; Liang Wang; Jing Luo; Qiong Zhu; Lei Wu; Xiaogang Zhang; Dan Chen
Journal:  Neurochem Res       Date:  2011-12-08       Impact factor: 3.996

2.  VEGF is an essential retrograde trophic factor for motoneurons.

Authors:  Paula M Calvo; Rosendo G Hernández; Rosa R de la Cruz; Angel M Pastor
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-21       Impact factor: 12.779

3.  Changes of biochemical biomarkers in the serum of children with convulsion status epilepticus: a prospective study.

Authors:  Manli Wang; Jian Yu; Xiao Xiao; Bingbing Zhang; Jihong Tang
Journal:  BMC Neurol       Date:  2022-05-27       Impact factor: 2.903

Review 4.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

5.  VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures.

Authors:  Litsa Nikitidou; Irene Kanter-Schlifke; Joke Dhondt; Peter Carmeliet; Diether Lambrechts; Mérab Kokaia
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

6.  Multiple Autologous Bone Marrow-Derived CD271+ Mesenchymal Stem Cell Transplantation Overcomes Drug-Resistant Epilepsy in Children.

Authors:  Olga Milczarek; Danuta Jarocha; Anna Starowicz-Filip; Stanislaw Kwiatkowski; Bogna Badyra; Marcin Majka
Journal:  Stem Cells Transl Med       Date:  2017-12-10       Impact factor: 6.940

Review 7.  Astroglial role in the pathophysiology of status epilepticus: an overview.

Authors:  Karina Vargas-Sánchez; Maria Mogilevskaya; John Rodríguez-Pérez; María G Rubiano; José J Javela; Rodrigo E González-Reyes
Journal:  Oncotarget       Date:  2018-06-01

Review 8.  Vascular Integrity and Signaling Determining Brain Development, Network Excitability, and Epileptogenesis.

Authors:  Jugajyoti Baruah; Anju Vasudevan; Rüdiger Köhling
Journal:  Front Physiol       Date:  2020-01-22       Impact factor: 4.566

9.  A Single Intraventricular Injection of VEGF Leads to Long-Term Neurotrophic Effects in Axotomized Motoneurons.

Authors:  Paula M Calvo; Rosa R de la Cruz; Angel M Pastor
Journal:  eNeuro       Date:  2020-05-29

10.  Peroxisome Proliferator-Activated Receptor γ Coactivator 1α Activates Vascular Endothelial Growth Factor That Protects Against Neuronal Cell Death Following Status Epilepticus through PI3K/AKT and MEK/ERK Signaling.

Authors:  Jyun-Bin Huang; Shih-Pin Hsu; Hsiu-Yung Pan; Shang-Der Chen; Shu-Fang Chen; Tsu-Kung Lin; Xuan-Ping Liu; Jie-Hau Li; Nai-Ching Chen; Chia-Wei Liou; Chung-Yao Hsu; Hung-Yi Chuang; Yao-Chung Chuang
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.